BAYER PHARMA AG based in Berlin, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-08-03 ✅ Patent 10,059,707 granted on 2018-08-28

US20170217957A1

Chemistry; metallurgy

Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro- 1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient

#2 | 2015-06-25

US20150174142A1

Human necessities

MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS

#3 | 2014-05-08 ✅ Patent 9,126,998 granted on 2015-09-08

US20140128372A1

Chemistry; metallurgy

Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use

#4 | 2013-08-29 ✅ Patent 9,095,691 granted on 2015-08-04

US20130226113A1

Human necessities

UV stable transdermal therapeutic plaster with a UV absorbing self-adhesive layer separated from the drug matrix

#5 | 2013-07-11 ✅ Patent 11,617,751 granted on 2023-04-04

US20130178452A1

Human necessities

Pharmaceutical composition containing a tetrahydrofolic acid

#6 | 2013-06-27

US20130165421A1

Chemistry; metallurgy

4-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)

#7 | 2013-04-18 ✅ Patent 8,992,932 granted on 2015-03-31

US20130095123A1

Chemistry; metallurgy

Binder-drug conjugates (ADCs) and use thereof

#8 | 2013-04-11

US20130089574A1

Human necessities

METHOD OF PREVENTIVE ON-DEMAND HORMONAL CONTRACEPTION

#9 | 2013-01-03 ✅ Patent 8,680,117 granted on 2014-03-25

US20130005766A1

Chemistry; metallurgy

5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

#10 | 2012-11-15 ✅ Patent 8,461,346 granted on 2013-06-11

US20120289510A1

Chemistry; metallurgy

Benzyl amines, a process for their production and their use as anti-inflammatory agents

#11 | 2012-09-06

US20120225853A1

Human necessities

HORMONE REPLACEMENT THERAPY AND DEPRESSION

#12 | 2012-08-09

US20120202779A1

Human necessities

MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS

#13 | 2012-08-02 ✅ Patent 8,597,568 granted on 2013-12-03

US20120195791A1

Human necessities

Method for deactivating undesired contaminations in leech extracts

#14 | 2012-06-05 ✅ Patent 8,193,252 granted on 2012-06-05

US10450029

Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders

#15 | 2012-03-29 ✅ Patent 8,314,248 granted on 2012-11-20

US20120077984A1

Chemistry; metallurgy

Process for preparing epothilone derivatives by selective catalytic epoxidation

#16 | 2011-12-13 ✅ Patent 8,076,317 granted on 2011-12-13

US10380405

Contraception process and administration form for the same

#17 | 2011-12-08 ✅ Patent 8,173,676 granted on 2012-05-08

US20110301347A1

Chemistry; metallurgy

Benzyl, amines, a process for their production and their use as anti-inflammatory agents

#18 | 2011-11-10 ✅ Patent 8,658,788 granted on 2014-02-25

US20110275796A1

Chemistry; metallurgy

Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes

#19 | 2011-10-20 ✅ Patent 8,324,412 granted on 2012-12-04

US20110257142A1

Chemistry; metallurgy

Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil)

#20 | 2011-05-26 ✅ Patent 8,049,035 granted on 2011-11-01

US20110124910A1

Chemistry; metallurgy

Crystalline potassium salt of lipoxin Aanalogs

#21 | 2011-04-14 ✅ Patent 8,343,745 granted on 2013-01-01

US20110086013A1

Chemistry; metallurgy

Acylglycerol acyltransferase-like protein MGAT-X1 and uses thereof

#22 | 2010-11-25 ✅ Patent 8,399,627 granted on 2013-03-19

US20100297700A1

Chemistry; metallurgy

Antibodies to TNFα

#23 | 2010-09-09 ✅ Patent 8,439,868 granted on 2013-05-14

US20100228228A1

Human necessities

Medical device for dispersing medicaments

#24 | 2010-06-10 ✅ Patent 8,097,627 granted on 2012-01-17

US20100144742A1

Chemistry; metallurgy

Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents

#25 | 2009-05-28 ✅ Patent 8,394,958 granted on 2013-03-12

US20090137564A1

Chemistry; metallurgy

5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

#26 | 2009-02-19 ✅ Patent 8,207,150 granted on 2012-06-26

US20090048217A1

Chemistry; metallurgy

17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative

#27 | 2008-11-27 ✅ Patent 8,557,776 granted on 2013-10-15

US20080292548A1

Chemistry; metallurgy

Compounds and methods for F labeled agents

#28 | 2007-08-16 ✅ Patent 8,084,457 granted on 2011-12-27

US20070191344A1

Chemistry; metallurgy

Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases

#29 | 2007-01-25 ✅ Patent 8,047,372 granted on 2011-11-01

US20070017847A1

Performing operations; transporting

Case for receiving a medicament pack, and use thereof

#30 | 2006-06-15 ✅ Patent 8,501,720 granted on 2013-08-06

US20060128679A1

Human necessities

Method for treatment of dysmenorrhea

#31 | 2005-11-10 ✅ Patent 8,163,721 granted on 2012-04-24

US20050250747A1

Human necessities

Management of breakthrough bleeding in extended hormonal contraceptive regimens

Also check out Bayer Pharma AG's (Berlin, Germany) applicant profile with 1 patent applications submitted.

AssigneeID:

1960 ⎘